GLENMARK

Glenmark Pharmaceuticals Share Price Glenmark Pharmaceuticals

₹918.6
-21.05 (-2.24%)
  • Advice
  • Hold
19 March, 2024 12:01 BSE: 532296 NSE: GLENMARKISIN: INE935A01035

Start SIP in Glenmark Pharmaceuticals

Start SIP

Glenmark Pharmaceuticals Performance

Day Range

  • Low 918
  • High 942
₹ 918

52 Week Range

  • Low 424
  • High 974
₹ 918
  • Open Price939
  • Previous Close940
  • Volume294329

Glenmark Pharmaceuticals Share Price

  • Over 1 Month 5.31%
  • Over 3 Month 12.39%
  • Over 6 Month 7.87%
  • Over 1 Year 108.37%

Glenmark Pharmaceuticals Key Statistics

P/E Ratio -30.9
PEG Ratio 0.2
Market Cap Cr 25,922
Price to Book Ratio 2.6
EPS 55.9
Dividend 0.3
Relative Strength Index 56.62
Money Flow Index 70.13
MACD Signal 15.6
Average True Range 33.8
Glenmark Pharmaceuticals Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 1,3652,2332,1441,875
Operating Expenses Qtr Cr 1,5491,7631,6591,721
Operating Profit Qtr Cr -184471485218
Depreciation Qtr Cr 51504947
Interest Qtr Cr 74586259
Tax Qtr Cr -5587120-176
Net Profit Qtr Cr -20302272-137
IndicatorMar 2023
Total Revenue Annual Cr 9,207
Operating Expenses Annual Cr 6,748
Operating Profit Annual in Cr 1,473
Depreciation Cr 184
Interest Annual Cr 207
Tax Annual Cr 363
Net Profit Annual Cr 1,209
IndicatorMar 2023
Cash from Operating Activity Annual Cr 1,474
Cash from Investing Activity Annual Cr -431
Cash from Financing Annual Activity Cr -978
Net Cash Flow Annual Cr 64
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 17,877
Fixed Assets Annual Cr 1,918
Total Non Current Assets Annual Cr 20,201
Total Current Assets Annual Cr 4,385
Total Assets Annual Cr 24,586
IndicatorMar 2023
Book Value Per Share Annual Rs 634
ROE Annual % 7
ROCE Annual % 11
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 30
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 2,5073,2073,4023,301
Operating Expenses Qtr Cr 2,7152,7452,7702,769
Operating Profit Qtr Cr -209462631605
Depreciation Qtr Cr 147141155147
Interest Qtr Cr 134121112109
Tax Qtr Cr -7256160-88
Net Profit Qtr Cr -351-8223-428
IndicatorMar 2023
Total Revenue Annual Cr 13,307
Operating Expenses Annual Cr 10,712
Operating Profit Annual in Cr 2,278
Depreciation Cr 611
Interest Annual Cr 350
Tax Annual Cr 491
Net Profit Annual Cr 297
IndicatorMar 2023
Cash from Operating Activity Annual Cr 625
Cash from Investing Activity Annual Cr -528
Cash from Financing Annual Activity Cr -77
Net Cash Flow Annual Cr 19
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 9,474
Fixed Assets Annual Cr 7,380
Total Non Current Assets Annual Cr 9,498
Total Current Assets Annual Cr 9,874
Total Assets Annual Cr 19,372
IndicatorMar 2023
Book Value Per Share Annual Rs 349
ROE Annual % 3
ROCE Annual % 14
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 20

Glenmark Pharmaceuticals Technicals

EMA & SMA

Current Price
₹918.6
-21.05 (-2.24%)
pointer
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • ₹919.04
  • 50 Day
  • ₹892.36
  • 100 Day
  • ₹855.69
  • 200 Day
  • ₹784.25
  • 20 Day
  • ₹923.53
  • 50 Day
  • ₹892.57
  • 100 Day
  • ₹845.12
  • 200 Day
  • ₹795.95

Glenmark Pharmaceuticals Resistance and Support

PIVOT
₹933.44
Resistance
First Resistance 950.82
Second Resistance 961.98
Third Resistance 979.37
RSI 56.62
MFI 70.13
MACD Single Line 15.60
MACD 14.83
Support
First Resistance 922.27
Second Resistance 904.88
Third Resistance 893.72

Glenmark Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 692,160 29,188,387 42.17
Week 1,281,772 56,167,258 43.82
1 Month 1,393,062 51,752,271 37.15
6 Month 1,420,041 44,035,483 31.01

Glenmark Pharmaceuticals Result Highlights

Glenmark Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Glenmark Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 8220.66 Cr. and Equity Capital is Rs. 28.22 Cr. for the Year ended 31/03/2023. Glenmark Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/11/1977 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24299MH1977PLC019982 and registration number is 019982.
Market Cap 26,516
Sales 7,682
Shares in Float 14.96
No of funds 287
Yield 0.27
Book Value 1.48
U/D Vol ratio 1.7
LTDebt / Equity 15
Alpha 0.17
Beta 1.2

Glenmark Pharmaceuticals

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 46.65%46.65%46.65%46.65%
Mutual Funds 8.59%7.3%5.36%5.43%
Insurance Companies 1.68%2.44%3.18%4.41%
Foreign Portfolio Investors 23.71%24.79%25.51%22.47%
Financial Institutions/ Banks 0.2%0.2%0.2%0.2%
Individual Investors 14.78%14.84%15.2%16.9%
Others 4.39%3.78%3.9%3.94%

Glenmark Pharmaceuticals Management

Name Designation
Mr. Glenn Saldanha Chairman & Managing Director
Mrs. Cherylann Pinto Executive Director - Corporate Affairs
Mr. V S Mani Executive Director & Global CFO
Mr. Rajesh V Desai Ind. Non-Executive Director
Dr. Brian W Tempest Ind. Non-Executive Director
Mr. Dipankar Bhattacharjee Ind. Non-Executive Director
Mr. Bernard Munos Ind. Non-Executive Director
Mr. Sridhar Gorthi Ind. Non-Executive Director
Mrs. Vijayalakshmi Iyer Ind. Non-Executive Director
Mr. D R Mehta Ind. Non-Executive Director
Ms. Saira Ramasastry Ind. Non-Executive Director
Mrs. B E Saldanha Non Executive Director

Glenmark Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Glenmark Pharmaceuticals Corporate Action

Date Purpose Remarks
2024-02-14 Quarterly Results
2023-11-10 Quarterly Results
2023-08-11 Quarterly Results
2023-05-19 Audited Results & Final Dividend
2023-02-10 Quarterly Results

Glenmark Pharmaceuticals FAQs

What is Share Price of Glenmark Pharmaceuticals ?

Glenmark Pharmaceuticals share price is ₹918 As on 19 March, 2024 | 11:47

What is the Market Cap of Glenmark Pharmaceuticals ?

The Market Cap of Glenmark Pharmaceuticals is ₹25921.8 Cr As on 19 March, 2024 | 11:47

What is the P/E ratio of Glenmark Pharmaceuticals ?

The P/E ratio of Glenmark Pharmaceuticals is -30.9 As on 19 March, 2024 | 11:47

What is the PB ratio of Glenmark Pharmaceuticals ?

The PB ratio of Glenmark Pharmaceuticals is 2.6 As on 19 March, 2024 | 11:47

Q2FY23